EVEX vs NUTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NUTX Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nutex Health Inc. Common Stock (NUTX) driven by superior Valuation, Growth & Margin, Momentum & Technical while EVEX counters with relative strength in Options & Structure. Fundamentally, EVEX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NUTX at 6.2x Forward P/E and 53.7% operating margin (-18.7% YoY). In options structure, EVEX sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against NUTX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EVEX | NUTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $597.7M | $1.2B | Larger Scale | NUTX |
| Trailing P/E Ratio Valuation | N/M | 7.5x | Lower Multiple | NUTX |
| Forward P/E Ratio Valuation | N/M | 6.2x | Lower Multiple | NUTX |
| Revenue Growth (YoY) Growth | +0.0% | -18.7% | Higher Growth | EVEX |
| Operating Margin (TTM) Profitability | 0.0% | 53.7% | Higher Margin | NUTX |
| Net Profit Margin Profitability | 0.0% | 20.7% | Higher Margin | NUTX |
| Return on Equity (ROE) Capital Efficiency | -300.9% | 47.6% | Higher ROE | NUTX |
| 52-Week Range Position Momentum | 8% ($1โ$5) | 58% ($84โ$226) | Stronger Trend | NUTX |
| Beta / 30D Volatility Risk Regime | 2.71ฮฒ ยท 96% Vol | 1.78ฮฒ ยท 86% Vol | Lower Realized Risk | NUTX |
| Unified Institutional Score Composite Signal | 41.3 / 100 (SELL) | 51.7 / 100 (HOLD) | Higher Composite | NUTX |